Open AccessDual specific CD19/CD22‑targeted chimeric antigen receptor T‑cell therapy for refractory diffuse large B‑cell lymphoma: A case report
Author(s) -
Chen Huang,
Huichao Zhang,
JinYuan Ho,
Ruixia Liu,
Lin Wang,
Na Kuang,
Meirong Zheng,
Lihong Liu,
Jianqiang Li
Publication year - 2020
Publication title -
oncology letters
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.766
H-Index - 54
eISSN - 1792-1082
pISSN - 1792-1074
DOI - 10.3892/ol.2020.11882
Subject(s) - chimeric antigen receptor , cd19 , cytokine release syndrome , medicine , cd22 , targeted therapy , lymphoma , refractory (planetary science) , cell therapy , diffuse large b cell lymphoma , oncology , cancer research , immunology , antigen , immunotherapy , cell , cancer , biology , genetics , astrobiology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom